M1-like monocytes are a major immunological determinant of severity in previously healthy adults with life-threatening influenza
暂无分享,去创建一个
A. McMichael | V. Cerundolo | S. Taylor | J. McCauley | F. Liew | K. Benam | W. Barclay | M. Zambon | J. Dunning | P. Openshaw | F. Martínez | E. Repapi | L. Ho | T. Dong | L. Drumright | S. Cole | T. Powell | A. Benlahrech | Ruth A. Elderfield | W. Kok | Michael J. Bennett | C. Thomas | Michael Bennett
[1] K. Benam,et al. How the Respiratory Epithelium Senses and Reacts to Influenza Virus , 2019, American journal of respiratory cell and molecular biology.
[2] H. Rosenberg,et al. Critical Adverse Impact of IL-6 in Acute Pneumovirus Infection , 2019, The Journal of Immunology.
[3] L. Ho,et al. Contribution of innate immune cells to pathogenesis of severe influenza virus infection. , 2017, Clinical science.
[4] P. Thomas,et al. Balancing Immune Protection and Immune Pathology by CD8+ T-Cell Responses to Influenza Infection , 2016, Front. Immunol..
[5] J. Mejía-Aranguré,et al. TNF, IL6, and IL1B Polymorphisms Are Associated with Severe Influenza A (H1N1) Virus Infection in the Mexican Population , 2015, PloS one.
[6] A. Till,et al. Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease. , 2015, Cell metabolism.
[7] Paul Kellam,et al. Accumulation of Human-Adapting Mutations during Circulation of A(H1N1)pdm09 Influenza Virus in Humans in the United Kingdom , 2014, Journal of Virology.
[8] S. Goerdt,et al. Macrophage activation and polarization: nomenclature and experimental guidelines. , 2014, Immunity.
[9] Akiko Iwasaki,et al. Innate immunity to influenza virus infection , 2014, Nature Reviews Immunology.
[10] S. Gordon,et al. The M1 and M2 paradigm of macrophage activation: time for reassessment , 2014, F1000prime reports.
[11] P. Goepfert,et al. Immune Suppression by Neutrophils in HIV-1 Infection: Role of PD-L1/PD-1 Pathway , 2014, PLoS pathogens.
[12] R. Webby,et al. Mucosal immune responses predict clinical outcomes during influenza infection independently of age and viral load. , 2014, American journal of respiratory and critical care medicine.
[13] T. Hussell,et al. Alveolar macrophages: plasticity in a tissue-specific context , 2014, Nature Reviews Immunology.
[14] L. Beckers,et al. Reprogramming macrophages to an anti‐inflammatory phenotype by helminth antigens reduces murine atherosclerosis , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[15] H. Perlman,et al. Flow cytometric analysis of macrophages and dendritic cell subsets in the mouse lung. , 2013, American journal of respiratory cell and molecular biology.
[16] C. Karp,et al. Role of the Lipoxygenase Pathway in RSV-induced Alternatively Activated Macrophages Leading to Resolution of Lung Pathology , 2013, Mucosal Immunology.
[17] P. Thomas,et al. Depletion of Alveolar Macrophages during Influenza Infection Facilitates Bacterial Superinfections , 2013, The Journal of Immunology.
[18] Xiang Gao,et al. Bacterial colonization dampens influenza-mediated acute lung injury via induction of M2 alveolar macrophages , 2013, Nature Communications.
[19] Tao Dong,et al. Examination of Influenza Specific T Cell Responses after Influenza Virus Challenge in Individuals Vaccinated with MVA-NP+M1 Vaccine , 2013, PloS one.
[20] C. Carmona-Rivera,et al. Low-density granulocytes: a distinct class of neutrophils in systemic autoimmunity , 2013, Seminars in Immunopathology.
[21] S. Gordon,et al. Genetic programs expressed in resting and IL-4 alternatively activated mouse and human macrophages: similarities and differences. , 2013, Blood.
[22] Dayan Wang,et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals , 2013, Nature Communications.
[23] I. Müller,et al. Characterization of a Novel Population of Low-Density Granulocytes Associated with Disease Severity in HIV-1 Infection , 2012, PloS one.
[24] J. Knight,et al. Lupus neutrophils: ‘NET’ gain in understanding lupus pathogenesis , 2012, Current opinion in rheumatology.
[25] M. Jordana,et al. Critical role of natural killer cells in lung immunopathology during influenza infection in mice. , 2012, The Journal of infectious diseases.
[26] Jean H. Chang,et al. Implication of Inflammatory Macrophages, Nuclear Receptors, and Interferon Regulatory Factors in Increased Virulence of Pandemic 2009 H1N1 Influenza A Virus after Host Adaptation , 2012, Journal of Virology.
[27] Paul Kellam,et al. IFITM3 restricts the morbidity and mortality associated with influenza , 2012, Nature.
[28] A. McMichael,et al. Pivotal Advance: Invariant NKT cells reduce accumulation of inflammatory monocytes in the lungs and decrease immune‐pathology during severe influenza A virus infection , 2012, Journal of leukocyte biology.
[29] D. Hume,et al. Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. , 2012, Blood.
[30] E. Pamer,et al. Monocyte recruitment during infection and inflammation , 2011, Nature Reviews Immunology.
[31] J. Rello,et al. Imbalanced pro- and anti-Th17 responses (IL-17/granulocyte colony-stimulating factor) predict fatal outcome in 2009 pandemic influenza , 2011, Critical care.
[32] P. Zabel,et al. Myeloid‐derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties , 2011, Journal of leukocyte biology.
[33] Michael R. Elliott,et al. Identification of a Novel Macrophage Phenotype That Develops in Response to Atherogenic Phospholipids via Nrf2 , 2010, Circulation research.
[34] Tao Dong,et al. Reduction of Natural Killer but Not Effector CD8 T Lymphoyctes in Three Consecutive Cases of Severe/Lethal H1N1/09 Influenza A Virus Infection , 2010, PloS one.
[35] J. M. Bernal-Blanco,et al. Severe Pneumonia Associated with Pandemic (H1N1) 2009 Outbreak, San Luis Potosí, Mexico , 2010, Emerging infectious diseases.
[36] Robert Schechter,et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. , 2009, JAMA.
[37] Jessica K. Alexander,et al. Identification of Two Distinct Macrophage Subsets with Divergent Effects Causing either Neurotoxicity or Regeneration in the Injured Mouse Spinal Cord , 2009, The Journal of Neuroscience.
[38] L. Becker,et al. Single Nucleotide Polymorphisms in Monocyte Chemoattractant Protein-1 and Its Receptor Act Synergistically to Increase the Risk of Carotid Atherosclerosis , 2009, Cerebrovascular Diseases.
[39] Scott A. Brown,et al. TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection , 2009, Proceedings of the National Academy of Sciences.
[40] Israel Steinfeld,et al. BMC Bioinformatics BioMed Central , 2008 .
[41] Matthias Mack,et al. Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand , 2008, The Journal of experimental medicine.
[42] Anneliese O. Speak,et al. Invariant NKT cells reduce the immunosuppressive activity of influenza A virus-induced myeloid-derived suppressor cells in mice and humans. , 2008, The Journal of clinical investigation.
[43] Lucy A. Perrone,et al. H5N1 and 1918 Pandemic Influenza Virus Infection Results in Early and Excessive Infiltration of Macrophages and Neutrophils in the Lungs of Mice , 2008, PLoS pathogens.
[44] E. Ramsburg,et al. CCR2+ Monocyte-Derived Dendritic Cells and Exudate Macrophages Produce Influenza-Induced Pulmonary Immune Pathology and Mortality1 , 2008, The Journal of Immunology.
[45] R. Webster,et al. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection , 2007, Proceedings of the National Academy of Sciences.
[46] P. Doherty,et al. A question of self‐preservation: immunopathology in influenza virus infection , 2007, Immunology and cell biology.
[47] Yi Guan,et al. Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia , 2006, Nature Medicine.
[48] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[49] Angus Nicoll,et al. Avian influenza A (H5N1) infection in humans. , 2005, The New England journal of medicine.
[50] Silvano Sozzani,et al. The chemokine system in diverse forms of macrophage activation and polarization. , 2004, Trends in immunology.
[51] Z. Makita,et al. Interferon-γ-induced apoptosis and activation of THP-1 macrophages , 2002 .
[52] Roger E Bumgarner,et al. Cellular transcriptional profiling in influenza A virus-infected lung epithelial cells: The role of the nonstructural NS1 protein in the evasion of the host innate defense and its potential contribution to pandemic influenza , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[53] N. Maeda,et al. Contrasting effects of CCR5 and CCR2 deficiency in the pulmonary inflammatory response to influenza A virus. , 2000, The American journal of pathology.
[54] K. Reeth. Cytokines in the pathogenesis of influenza. , 2000 .
[55] A. Kumar,et al. Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans , 2010 .
[56] Z. Makita,et al. Interferon-gamma-induced apoptosis and activation of THP-1 macrophages. , 2002, Life sciences.